Comparisons of Costs between Black Caribbean and White British Patients with Advanced Multiple Sclerosis in the UK
- PMID: 24649365
- PMCID: PMC3932720
- DOI: 10.1155/2014/613701
Comparisons of Costs between Black Caribbean and White British Patients with Advanced Multiple Sclerosis in the UK
Abstract
Background. Multiple sclerosis (MS) is now more common among black and minority ethnic groups in the UK but little is known about the costs of care amongst different ethnic groups. Objective. This study examined and compared service use and costs for people severely affected with MS from Black Caribbean (BC) and White British (WB) backgrounds in the UK and identified predictors of cost for both groups. Method. Population-based cross-sectional study of 43 BC and 43 WB patients with MS (EDSS ≥ 6) and their informal caregivers recruited from an MS service in southeast London. Interviews collected data on health and social service use and informal care support. Costs were calculated using UK unit cost data. Using regression analyses we compared costs between the ethnic groups and identified possible predictors of cost. Results. The mean (SD) costs for the WB and BC groups were £ 25,778 ( £ 39,387) and £ 23,186 ( £ 30,433), respectively. Results identified no significant difference in total cost between the two ethnic groups. The EDSS score alone was a significant predictor of cost. Conclusion. Similar costs between ethnic groups indicate that with regard to this MS service and geographical area, access to care was not affected by ethnicity.
Figures








References
-
- Julian L, Merluzzi NM, Mohr DC. The relationship among depression, subjective cognitive impairment, and neuropsychological performance in multiple sclerosis. Multiple Sclerosis. 2007;13(1):81–86. - PubMed
-
- Higginson IJ, Hart S, Silber E, Burman R, Edmonds P. Symptom prevalence and severity in people severely affected by multiple sclerosis. Journal of Palliative Care. 2006;22(3):158–165. - PubMed
-
- Steinman L. Multiple sclerosis: two-stage disease. Nature Immunology. 2001;2(9):762–764. - PubMed
-
- Higginson IJ, McCrone P, Hart SR, Burman R, Silber E, Edmonds PM. Is short-term palliative care cost-effective in multiple sclerosis? A randomized phase II trial. Journal of Pain and Symptom Management. 2009;38(6):816–826. - PubMed
-
- McCrone P, Heslin M, Knapp M, Bull P, Thompson A. Multiple sclerosis in the UK: service use, costs, quality of life and disability. PharmacoEconomics. 2008;26(10):847–860. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources